(Q34209536)
English
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial.
scientific article
Statements
1 reference
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. (English)
1 reference
John G F Cleland
1 reference
John R Teerlink
1 reference
Roxy Senior
1 reference
Evgeny M Nifontov
1 reference
John J V Mc Murray
1 reference
Chim C Lang
1 reference
Vitaly A Tsyrlin
1 reference
Barry H Greenberg
1 reference
Jamil Mayet
1 reference
Darrel P Francis
1 reference
Tamaz Shaburishvili
1 reference
Mark Monaghan
1 reference
Mitchell Saltzberg
1 reference
Ludwig Neyses
1 reference
Scott M Wasserman
1 reference
Jacqueline H Lee
1 reference
Khalil G Saikali
1 reference
Cyril P Clarke
1 reference
Jonathan H Goldman
1 reference
Andrew A Wolff
1 reference
Fady I Malik
1 reference
1 August 2011
1 reference
1 reference
378
1 reference
9792
1 reference
676-683
1 reference
Identifiers
1 reference
1 reference